Literature DB >> 15687318

Malignant gliomas in 2005: where to GO from here?

Paul Graham Fisher, Patricia A Buffler.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15687318     DOI： 10.1001/jama.293.5.615

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  24 in total

Review 1.  Novel delivery strategies for glioblastoma.

Authors:  Jiangbing Zhou; Kofi-Buaku Atsina; Benjamin T Himes; Garth W Strohbehn; W Mark Saltzman
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

2.  Allergic conditions reduce the risk of glioma: a meta-analysis based on 128,936 subjects.

Authors:  Hongyu Zhao; Weisong Cai; Shitao Su; Debao Zhi; Jie Lu; Shuo Liu
Journal:  Tumour Biol       Date:  2013-12-18

3.  Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography.

Authors:  Beata Chertok; Allan E David; Victor C Yang
Journal:  J Control Release       Date:  2011-07-07       Impact factor: 9.776

4.  Effect of treatment with baicalein on the intracerebral tumor growth and survival of orthotopic glioma models.

Authors:  Fu-Rong Wang; Yong-Sheng Jiang
Journal:  J Neurooncol       Date:  2015-05-13       Impact factor: 4.130

5.  Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration.

Authors:  Beata Chertok; Allan E David; Victor C Yang
Journal:  Biomaterials       Date:  2010-05-21       Impact factor: 12.479

Review 6.  Targeting astrocytomas and invading immune cells with cannabinoids: a promising therapeutic avenue.

Authors:  Eiron Cudaback; Nephi Stella
Journal:  Mol Neurobiol       Date:  2007-07-03       Impact factor: 5.590

7.  Glutathione S-transferase M1, T1, and P1 polymorphisms and risk of glioma: a meta-analysis.

Authors:  Zuoxu Fan; Yaoyao Wu; Jian Shen; Renya Zhan
Journal:  Mol Biol Rep       Date:  2012-10-20       Impact factor: 2.316

Review 8.  Targeting glioblastoma-derived pericytes improves chemotherapeutic outcome.

Authors:  Daniel A P Guerra; Ana E Paiva; Isadora F G Sena; Patrick O Azevedo; Walison N Silva; Akiva Mintz; Alexander Birbrair
Journal:  Angiogenesis       Date:  2018-05-14       Impact factor: 9.596

9.  Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors.

Authors:  Beata Chertok; Bradford A Moffat; Allan E David; Faquan Yu; Christian Bergemann; Brian D Ross; Victor C Yang
Journal:  Biomaterials       Date:  2007-10-26       Impact factor: 12.479

10.  Fasting enhances the response of glioma to chemo- and radiotherapy.

Authors:  Fernando Safdie; Sebastian Brandhorst; Min Wei; Weijun Wang; Changhan Lee; Saewon Hwang; Peter S Conti; Thomas C Chen; Valter D Longo
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.